4//SEC Filing
Sholehvar David 4
Accession 0001077183-22-000128
CIK 0001077183other
Filed
Aug 2, 8:00 PM ET
Accepted
Aug 3, 5:45 PM ET
Size
8.3 KB
Accession
0001077183-22-000128
Insider Transaction Report
Form 4
Sholehvar David
President, Clinical Services
Transactions
- Award
Stock Option (Right to Buy)
2022-08-01+25,826→ 25,826 totalExercise: $10.12Exp: 2029-08-01→ Common Stock (25,826 underlying) - Award
Common Stock
2022-08-01+12,352→ 43,216 total
Holdings
- 66,372
Stock Option (Right to Buy)
Exercise: $12.15Exp: 2029-04-01→ Common Stock (66,372 underlying)
Footnotes (3)
- [F1]On August 1, 2022, Dr. Sholehvar was granted 12,352 restricted stock awards. These awards vest ratably over the first four anniversary dates of the grant date.
- [F2]On April 1, 2022, Dr. Sholehvar was granted 66,372 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- [F3]On August 1, 2022, Dr. Sholehvar was granted 25,826 stock options. These options vest ratably over the first four anniversary dates of the grant date.
Documents
Issuer
NEOGENOMICS INC
CIK 0001077183
Entity typeother
Related Parties
1- filerCIK 0001916426
Filing Metadata
- Form type
- 4
- Filed
- Aug 2, 8:00 PM ET
- Accepted
- Aug 3, 5:45 PM ET
- Size
- 8.3 KB